Literature DB >> 454560

Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.

Y Hashimoto, F Takaku, T Yamanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454560      PMCID: PMC2009950          DOI: 10.1038/bjc.1979.152

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

Review 1.  Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.

Authors:  L Cercek; B Cercek
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

2.  Rapid preparation of lymphocytes for tissue-typing.

Authors:  R Harris; E O Ukaejiofo
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

3.  Isolation of an "antigen" from malignant tumours.

Authors:  P R Carnegie; E A Caspary; E J Field
Journal:  Br J Cancer Suppl       Date:  1973-08

4.  Usefulness of the SCM test in the diagnosis of gastric cancer.

Authors:  F Takaku; T Yamanaka; Y Hashimoto
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

5.  Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.

Authors:  L Cercek; B Cercek; C I Franklin
Journal:  Br J Cancer       Date:  1974-05       Impact factor: 7.640

6.  Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.

Authors:  L Cercek; B Cercek
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

  6 in total
  2 in total

1.  Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.

Authors:  Y D Shi; Z S Tang; Z J Lian; C Z Lu; B G Xiao
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

2.  The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.

Authors:  H Mitchell; P Wood; C R Pentycross; E Abel; K D Bagshawe
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.